Yann Mazabraud
Corporate Officer/Principal bij RHYTHM PHARMACEUTICALS, INC.
Vermogen: 1 M $ op 30-04-2024
Actieve functies van Yann Mazabraud
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 05-10-2020 | - |
Loopbaan van Yann Mazabraud
Eerdere bekende functies van Yann Mazabraud
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| TREVI THERAPEUTICS, INC. | Corporate Officer/Principal | 01-11-2017 | 03-10-2020 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01-01-2016 | 01-10-2017 |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Corporate Officer/Principal | - | - |
Opleiding van Yann Mazabraud
| Groupe de Sup de Co La Rochelle | Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 4 |
| Frankrijk | 2 |
| Verenigd Koninkrijk | 2 |
Operationeel
| Corporate Officer/Principal | 4 |
| Graduate Degree | 1 |
Sectoraal
| Health Technology | 5 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| TREVI THERAPEUTICS, INC. | Health Technology |
| RHYTHM PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Health Technology |
- Beurs
- Insiders
- Yann Mazabraud
- Ervaring
